News & Events July

CTI Announces Complete Enrollment of the Isotechnika ISA247 Phase 2B Clinical Program for the Prevention of Rejection following Kidney Transplantation

July 5, 2007

CTI Clinical Trial and Consulting Services (CTI) announced the completion of patient enrolment in the Isotechnika Phase 2b trial assessing ISA247 for the prevention of kidney graft rejection following transplantation. Of the 332 patients enrolled, 148 patients have already completed the required six months of treatment. Isotechnika expects to have ...

Read More

Join Our Mailing List